PMID: 7023306Jun 1, 1981Paper

Cimetidine decreases theophylline clearance

The American Review of Respiratory Disease
J E JacksonR Dorr

Abstract

This study tested the hypothesis that cimetidine decreases theophylline clearance. Aminophylline (6 mg/kg) was administered intravenously both before and after cimetidine treatment in 5 healthy adults. Cimetidine (300 mg) was administered orally every 6 h for 2 days before and 18 h after the aminophylline dose. Plasma samples were collected before and for 24 h after each aminophylline dose, and theophylline concentrations were determined by an enzyme-mediated immunoassay technique. Cimetidine significantly decreased theophylline clearance, mean decrease, 39% (3.85 +/- 0.27 L/h control versus 2.34 +/- 0.23 L/h with cimetidine treatment, p less than 0.002). The apparent volume of distribution was unchanged (p greater than 0.5), whereas the elimination rate constant was significantly decreased by a mean of 42% (control, 0.091 +/- 0.013 h-1 versus 0.053 +/- 0.007 h-1 with cimetidine treatment, p less than 0.005). This corresponded to an average increase in elimination half-life of 73% (range, 50 to 97%). Cimetidine probably slowed theophylline elimination by relatively nonspecific inhibition of the hepatic microsomal mono-oxygenase system. This effect may produce clinically significant changes in serum theophylline concentrations.

Citations

Jul 11, 1991·Journal of Clinical Pharmacology·J A GaskaP H Vlasses
Dec 1, 1993·Journal of Clinical Pharmacology·K OhashiA Ebihara
Jan 1, 1987·European Journal of Clinical Pharmacology·S H CurryM M Wolfe
Jan 1, 1985·European Journal of Clinical Pharmacology·S H CurryM M Wolfe
Oct 1, 1982·European Journal of Clinical Pharmacology·J HarenbergE Weber
Dec 9, 1988·Pharmaceutisch Weekblad. Scientific Edition·W J WijnandsT M De Witte
May 1, 1983·Canadian Anaesthetists' Society Journal·J A Moffat, B Milne
Jan 1, 1985·Pharmacology & Therapeutics·M C GerberJ R Bianchine
Jan 1, 1988·Pharmacology & Therapeutics·J C Mucklow
Aug 1, 1990·Pharmacology & Toxicology·J E Nielsen-KudskC Siggaard
Nov 1, 1990·The Journal of Pharmacy and Pharmacology·T HasegawaK Miyamoto
May 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·J I O'RiordanM Hutchinson
Jan 1, 1983·Postgraduate Medical Journal·H C Thomas
Aug 6, 1999·Journal of Clinical Pharmacology·D E NixJ J Schentag
Jul 1, 1987·Medical Toxicology and Adverse Drug Experience·A Heath, K Knudsen
Jul 1, 1986·British Journal of Diseases of the Chest·I D JohnstonM R Hetzel
Jul 1, 1990·The Journal of Emergency Medicine·F J Zucchero, M J Hogan
Jul 1, 1989·Journal of Clinical Pharmacology·M B GutfeldN J Harrison
Nov 1, 1982·Journal of the American Geriatrics Society·P P Lamy
Sep 1, 1984·British Journal of Clinical Pharmacology·G J MacpheeM J Brodie
Feb 1, 1985·British Journal of Clinical Pharmacology·J G KellyD G McDevitt
Sep 1, 1983·British Journal of Clinical Pharmacology·P J ThompsonM Turner Warwick
Dec 1, 1985·British Journal of Clinical Pharmacology·W J WijnandsC L Van Herwaarden
Mar 1, 1982·Journal of the American Geriatrics Society·M A Jenike
Feb 1, 1986·British Journal of Clinical Pharmacology·S B ReeleC Metzler
May 1, 1989·Journal of Clinical Pharmacology·K F CremerK V Speeg
Sep 1, 1984·British Journal of Clinical Pharmacology·V J HarveyA F Lant
Oct 1, 1983·Acta Neurologica Scandinavica·J SonneP B Andreasen
Jan 1, 1997·Journal of the American Academy of Dermatology·D J Fader, T M Johnson
Jan 1, 1984·American Heart Journal·H R OchsD J Greenblatt
Mar 1, 1987·American Journal of Surgery·J R MayJ F Sisley
Jan 1, 1984·The American Journal of Medicine·A J Sedman
Jun 1, 1983·Epilepsia·R B SalemJ E Jordan
Jan 1, 1984·European Journal of Clinical Pharmacology·J J GrygielD J Birkett
Jan 1, 1983·Postgraduate Medical Journal·D C Flenley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Internal Medicine
N Telerman-ToppetC Cöers
British Journal of Clinical Pharmacology
I ReimannJ Frölich
British Journal of Clinical Pharmacology
A M BreckenridgeJ M Willoughby
© 2021 Meta ULC. All rights reserved